Received by email:
File: news release 2015.05.05.pdf
AMERICAN MANGANESE INC. REFILES INTERIM MD&A
May 5, 2015 � Vancouver, BC
American Manganese Inc. ("American Manganese" or the "Company")(TSX.V: AMY; Pink
Sheets: AMYZF; Frankfurt: 2AM) has refiled its management discussion and analysis for the 6-
month period ended January 31, 2015 (the "MD&A") on SEDAR. As a result of a review by the
British Columbia Securities Commission, the Company has made the following material
revisions to the MD&A:
Previous reference to a "mineral resource" on the Artillery Peak property has been
revised to clarify that it is an "indicated resource".
Since some of the "alternate cases" (with respect to economic valuations) outlined in
the preliminary feasibility study ("PFS") on the Artillery Peak project are no longer
current or valid, only the "base case" scenario is now included in the MD&A and the
net present value discounted at 8% is highlighted.
The MD&A now states:
o the electrolytic manganese metal ("EMM") price that was used to derive the
"base case" scenario in the PFS; and
o the approximate price range for EMM which prevailed during 2014.
About American Manganese Inc.
American Manganese Inc. is a diversified specialty and critical metal Company focusing on
potentially becoming the lowest cost producer of electrolytic manganese products from its
Arizona Manganese Project.
On behalf of Management
AMERICAN MANGANESE INC.
Larry W. Reaugh
President and Chief Executive Officer
Information Contacts:
Larry W. Reaugh
President and Chief Executive Officer
604-531-9639
Email: lreaugh@amymn.com
www.americanmanganeseinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
--->TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward
--->-looking
statements", which are statements about the future based on current expectations or beliefs. For this purpose , statem
--->ents of
historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve ris
--->ks and
uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should
--->not place
undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking
statements except as required by law.
--->Page 1 of 1
© 2024 Canjex Publishing Ltd. All rights reserved.